Skip to content

TriSalus Life Sciences, Inc. TLSI Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1

Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$182K+98.5%
NGL Energy Partners logo
NGL Energy PartnersNGL
$4.42M+218%
Research Solutions logo
Research SolutionsRSSS
$278.64K-88.4%
Ryan Specialty Holdings logo
Ryan Specialty HoldingsRYAN
$27.29M+294%
OraSure Technologies logo
OraSure TechnologiesOSUR
$93K-80.5%
Shift4 Payments logo
Shift4 PaymentsFOUR
$0+100%

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s business combination contingent consideration arrangements change in amount of contingent consideration liability1.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s business combination contingent consideration arrangements change in amount of contingent consideration liability1?
TriSalus Life Sciences, Inc. (TLSI) reported business combination contingent consideration arrangements change in amount of contingent consideration liability1 of -$7.4M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s business combination contingent consideration arrangements change in amount of contingent consideration liability1 changed year-over-year?
TriSalus Life Sciences, Inc.'s business combination contingent consideration arrangements change in amount of contingent consideration liability1 decreased by 1002.7% year-over-year, from $820K to -$7.4M.
What does business combination contingent consideration arrangements change in amount of contingent consideration liability1 mean?
This metric captures the periodic adjustment to the fair value of contingent consideration liabilities arising from business acquisitions. It reflects changes in the estimated payout obligations based on the probability of achieving specific performance milestones or financial targets. Fluctuations in this value indicate shifts in the expected future cost of past acquisitions.